## Abstract Sera from 14 patients with type 2 autoimmune hepatitis (anti‐LKM, positive) were investigated for evidence of hepatitis C virus (HCV) infection. Antibodies to HCV were detected in 13 patients by both commercial and “in‐house” ELlSAs and also by a second generation recombinant immunoblot
PFAPA and autoimmune hepatitis type 2: Is this a possible association?
✍ Scribed by C. Della Corte; M. D’Ambrosi; S. Minichiello; M. Tufano; S. Rinaldi; A. Vicinanza; F. Ferrari; R. Iorio
- Book ID
- 119228782
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 57 KB
- Volume
- 39
- Category
- Article
- ISSN
- 1590-8658
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Fifty-one patients with autoimmune hepatitis have been studied for HLA association by conventional serology and also by modified polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) genotyping. HLA-DR4 was significantly associated with autoimmune hepatitis (46 of 51 patients
Perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) have been recently defined as the most sensitive autoantibody of type 1 autoimmune hepatitis (AIH-1). Their prevalence in type 2 autoimmune hepatitis (AIH-2) has not yet been evaluated. The aim of the present study was to verify the associat
Autoimmune hepatitis (AIH) is characterized by an immune-mediated injury of the hepatic parenchyma of unknown pathogenesis. Type 2 AIH is identified by the presence of antiliver-kidney microsomes type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) autoantibodies. The current study shows that